Diyabet ve Covid-19 Pandemisi
Özet
Referanslar
International Diabetes Federation. IDF Diabetes Atlas tenth edition 2021. Online version of IDF Diabetes Atlas: www.idf.org/diabetesatlas.Erişim tarihi: 01.05.2025.
WHO. COVID-19 Coronavirus Pandemic. 2025. Available online:https://data.who.int/dashboards/covid19/cases (erişim tarihi 20.05.2025)
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–62,
Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: Unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;36(7): e3321332
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061–9,
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–5
Shrestha DB, Budhathoki P, Raut S, et al. New onset diabetes in COVID 19 and clinical outcomes: A systematic review and meta analysis.World J Virol 2021;10:275 87.
Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: Pros and cons. Diabetes 2008;57:2863 71
Bornstein SR, Rubino F, Khunti K, et all. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020; 8: 546–50
Rao S, Lau A, So HC. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care 2020;2020:dc200643
Fernandez C, Rysa J, Almgren P, et al. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Intern Med 2018;284(4):377–87,
Kulcsar KA, Coleman CM, Beck SE, et al. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERSCoV infection. JCI Insight 2019;4(20):e131774
Williamson EJ, Walker AJ, Bhaskaran K, et al . Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436.
Sönmez A, Demirci İ, Haymana C, et al. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study. Journal of Diabetes 2021;13:585-95
Kania M, Kon´ B , Kaminski K, et al. Diabetes as a risk factor of death in hospitalized COVID-19 patients-an analysis of a National Hospitalization Database from Poland, 2020. Front Endocrinol 2023;14:1161637
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of (?) patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049.
Akinosoglou K, Schinas G, Bletsa E, et al. Covid-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study. Microorganisms 2023;11(16);1416
Al-Salameh A, Lanoix JP, Bennis Y, et al. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes/Metab. Res. Rev. 2021Mar; 37(3): e3388
Bogler O, Raissi A, Colacci M, et al. Association Between Diabetes and Mortality Among Adult Patients Hospitalized With COVID-19: A Cohort Study of Hospitalized Adults in Ontario, Canada, and Copenhagen, Denmark. Can J Diabetes 2023; 47:352-358
Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 2020;14:813–821 5.
Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020;22:1897–1906
Lombardi A, Agarwal S, Schechter C, et al . In-hospital hyperglycemia is associated with worse outcomes in patients admitted with COVID-19. Diabetes Care,2022; 45(11):2683–2688.
Pasquel FJ, Messler J, Booth R, et al. Characteristics of and mortality associated with diabetic ketoacidosis among US patients hospitalized with or without COVID-19. JAMA Netw Open 2021;4:e211091
Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell 2024 Oct 3;187(20):5500-552
Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 2022; 10: 311–21
Khunti K, Prato SD, Mathieu C, et all. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021;44:2645–2655
Sathish, T, Kapoor N, Cao Y, et al. Proportion of Newly Diagnosed Diabetes in COVID-19 Patients: A Systematic Review and Meta-Analysis. Diabetes Obes. Metab. 2021; 23: 870–874
Fadini GP, Morieri ML, Boscari F, et al. Newly-Diagnosed Diabetes and Admission Hyperglycemia Predict COVID-19 Severity by Aggravating Respiratory Deterioration. Diabetes Res. Clin. Pract. 2020; 168:108374.
Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020;22:1897–1906
Unsworth R, Wallace S, Oliver NS, et al. Newonset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 2020;43:e170–e171
Ghosh A, Anjana RM, Shanthi Rani CS, et al.Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India study. Diabetes Metab Syndr 2021;15:215–220
Williams R, Jenkins DA, Ashcroft DM, et al. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study. Lancet Public Health 2020;5: e543–50.
Mansfield KE, Mathur R, Tazare J, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digital health 2021;3:e217–30.
Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol 2021;9:413–5
Holman N, Knighton P, O’Keefe J, et al. Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales. Diabetes Obes Metab 2021; 23: 2728–40.
Ratzki-Leewing AA, Ryan BL, Buchenberger JD, et al. COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study). BMJ Open 2021; 11: e049782.
Seidu S, Hambling C, Holmes P, et al. The impact of the COVID pandemic on primary care diabetes services in the UK: a crosssectional national survey of views of health professionals delivering diabetes care. Prim Care Diabetes 2022; 16: 257–63.
Vamos EP, Khunti K. Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase. BMJ Qual Saf 2022 Jul;31(7):483-485 2021
Violant-Holz V, Gallego-Jiménez MG, González-González CS, et al. Psychological health and physical activity levels during the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health 2020; 17: E9419
Chao AM, Wadden TA, Clark JM, et al. Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study. Diabetes Care 2022; 45: 74–82.
Alfarwan N, Hodkinson A, Panagioti M, et al. Clinical and cost-effectiveness of telemedicine amongpatients with type 2 diabetes in primary care: A systematicreview and meta-analysis. Diabetic Medicine. 2024;41:e15343.
Zhang A, Wang J, Wan X, et al. A meta-analysis of the effective-ness of telemedicine in glycemic management among patientswith type 2 diabetes in primary care. Int J Environ Res PublicHealth. 2022;19(7):4173
Silberman J, Wicks P, Patel S, et al. Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework. NPJ Digit Med. 2023;6(1):101
Fontecha J, González I, Barragán A, et al. Use and trends of diabetes self-management technologies: a correlation-based study. J Diabetes Res 2022 Jun 7;2022:5962001
Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health. 2019;40:127–146
Referanslar
International Diabetes Federation. IDF Diabetes Atlas tenth edition 2021. Online version of IDF Diabetes Atlas: www.idf.org/diabetesatlas.Erişim tarihi: 01.05.2025.
WHO. COVID-19 Coronavirus Pandemic. 2025. Available online:https://data.who.int/dashboards/covid19/cases (erişim tarihi 20.05.2025)
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–62,
Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: Unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;36(7): e3321332
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061–9,
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–5
Shrestha DB, Budhathoki P, Raut S, et al. New onset diabetes in COVID 19 and clinical outcomes: A systematic review and meta analysis.World J Virol 2021;10:275 87.
Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: Pros and cons. Diabetes 2008;57:2863 71
Bornstein SR, Rubino F, Khunti K, et all. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020; 8: 546–50
Rao S, Lau A, So HC. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care 2020;2020:dc200643
Fernandez C, Rysa J, Almgren P, et al. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Intern Med 2018;284(4):377–87,
Kulcsar KA, Coleman CM, Beck SE, et al. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERSCoV infection. JCI Insight 2019;4(20):e131774
Williamson EJ, Walker AJ, Bhaskaran K, et al . Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436.
Sönmez A, Demirci İ, Haymana C, et al. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study. Journal of Diabetes 2021;13:585-95
Kania M, Kon´ B , Kaminski K, et al. Diabetes as a risk factor of death in hospitalized COVID-19 patients-an analysis of a National Hospitalization Database from Poland, 2020. Front Endocrinol 2023;14:1161637
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of (?) patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049.
Akinosoglou K, Schinas G, Bletsa E, et al. Covid-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study. Microorganisms 2023;11(16);1416
Al-Salameh A, Lanoix JP, Bennis Y, et al. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes/Metab. Res. Rev. 2021Mar; 37(3): e3388
Bogler O, Raissi A, Colacci M, et al. Association Between Diabetes and Mortality Among Adult Patients Hospitalized With COVID-19: A Cohort Study of Hospitalized Adults in Ontario, Canada, and Copenhagen, Denmark. Can J Diabetes 2023; 47:352-358
Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 2020;14:813–821 5.
Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020;22:1897–1906
Lombardi A, Agarwal S, Schechter C, et al . In-hospital hyperglycemia is associated with worse outcomes in patients admitted with COVID-19. Diabetes Care,2022; 45(11):2683–2688.
Pasquel FJ, Messler J, Booth R, et al. Characteristics of and mortality associated with diabetic ketoacidosis among US patients hospitalized with or without COVID-19. JAMA Netw Open 2021;4:e211091
Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell 2024 Oct 3;187(20):5500-552
Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 2022; 10: 311–21
Khunti K, Prato SD, Mathieu C, et all. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021;44:2645–2655
Sathish, T, Kapoor N, Cao Y, et al. Proportion of Newly Diagnosed Diabetes in COVID-19 Patients: A Systematic Review and Meta-Analysis. Diabetes Obes. Metab. 2021; 23: 870–874
Fadini GP, Morieri ML, Boscari F, et al. Newly-Diagnosed Diabetes and Admission Hyperglycemia Predict COVID-19 Severity by Aggravating Respiratory Deterioration. Diabetes Res. Clin. Pract. 2020; 168:108374.
Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020;22:1897–1906
Unsworth R, Wallace S, Oliver NS, et al. Newonset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 2020;43:e170–e171
Ghosh A, Anjana RM, Shanthi Rani CS, et al.Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India study. Diabetes Metab Syndr 2021;15:215–220
Williams R, Jenkins DA, Ashcroft DM, et al. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study. Lancet Public Health 2020;5: e543–50.
Mansfield KE, Mathur R, Tazare J, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digital health 2021;3:e217–30.
Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol 2021;9:413–5
Holman N, Knighton P, O’Keefe J, et al. Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales. Diabetes Obes Metab 2021; 23: 2728–40.
Ratzki-Leewing AA, Ryan BL, Buchenberger JD, et al. COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study). BMJ Open 2021; 11: e049782.
Seidu S, Hambling C, Holmes P, et al. The impact of the COVID pandemic on primary care diabetes services in the UK: a crosssectional national survey of views of health professionals delivering diabetes care. Prim Care Diabetes 2022; 16: 257–63.
Vamos EP, Khunti K. Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase. BMJ Qual Saf 2022 Jul;31(7):483-485 2021
Violant-Holz V, Gallego-Jiménez MG, González-González CS, et al. Psychological health and physical activity levels during the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health 2020; 17: E9419
Chao AM, Wadden TA, Clark JM, et al. Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study. Diabetes Care 2022; 45: 74–82.
Alfarwan N, Hodkinson A, Panagioti M, et al. Clinical and cost-effectiveness of telemedicine amongpatients with type 2 diabetes in primary care: A systematicreview and meta-analysis. Diabetic Medicine. 2024;41:e15343.
Zhang A, Wang J, Wan X, et al. A meta-analysis of the effective-ness of telemedicine in glycemic management among patientswith type 2 diabetes in primary care. Int J Environ Res PublicHealth. 2022;19(7):4173
Silberman J, Wicks P, Patel S, et al. Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework. NPJ Digit Med. 2023;6(1):101
Fontecha J, González I, Barragán A, et al. Use and trends of diabetes self-management technologies: a correlation-based study. J Diabetes Res 2022 Jun 7;2022:5962001
Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health. 2019;40:127–146
